Omnes Capital

Omnes Capital, established in 1999, is a prominent Paris-based private equity firm with €4.8 billion in assets under management. It specializes in providing growth capital to innovative small and medium-sized enterprises (SMEs), with a focus on technology and healthcare sectors. The firm has a proven track record, having supported over 120 companies and facilitated 65 business exits, including 14 initial public offerings (IPOs), over the past 16 years. Omnes Capital's expertise spans venture capital, buyout & growth capital, private debt, renewable energy, and co-investment strategies, making it a key player in France's private equity landscape.

Guillaume Blavier

Associate

Guillaume Blavier

Associate, Deeptech

Xavier Brunaud

Director, Venture Capital

Romain Campi

Principal

Antoine Colboc

Head of Venture Capital

Jean-Baptiste Delattre

Director

Julie Delclaux

Associate

Rémy Deloffre

Associate

Simon Hardi

Partner

Morgane Honikman

Director

Morgane Honikman

Partner

Hugo Hubert

Principal, Deeptech

Maia Korradi

Principal

Yasmine Lazrak

Principal

Camille Léonard

Associate

Bernard Nabet

Director and Head of Israel Office

Laurent Perret

Director

Fabien Prevost

Chief Investment Officer and Chairman

Sylvia Raussin

Investment Manager

Eric Rey

Managing Partner

Benjamin Stremsdoerfer

Partner

Aymeric de Susbielle

Associate

Philippe Trolez

Corporate Secretary, Partner and Member of the Executive Committee

Yannic Trueb

Director

Gonzague de Trémiolles

Partner

Caroline Yametti

Partner and Director

Philippe Zurawski

Partner

Past deals in Southern Europe

VSORA

Venture Round in 2025
VSORA is an intellectual property provider based in France, specializing in digital signal processing (DSP) technology for semiconductor chips used in advanced digital communications systems, including 5G networks. Founded in 2015 by a team of experienced DSP engineers, the company offers a powerful multi-core DSP architecture that eliminates the need for DSP co-processors, allowing for greater flexibility akin to software programming. VSORA's innovative DSP development flow facilitates collaboration between signal processing and software engineers, significantly accelerating time-to-market for new products. The company focuses on enhancing DSP computing power while optimizing power consumption and performance, ultimately reducing the silicon footprint required for complex integrated circuits.

Unseenlabs

Series C in 2024
Unseenlabs is a French company founded in 2015 and headquartered in Rennes, Brittany, specializing in marine surveillance services. The company designs and develops advanced spectrum surveillance payloads that enable the detection and tracking of non-cooperative vessels worldwide. Unseenlabs offers comprehensive solutions that encompass satellite design, deployment, and operational support. By launching satellites that can detect and geolocate signals and electromagnetic waves emitted by ships, Unseenlabs provides clients with the capability to monitor maritime activities, even when vessels disable their Automatic Identification System beacons. This technology is particularly valuable for identifying illegal operations such as fishing violations, degassing, and maritime piracy.

PeopleSpheres

Venture Round in 2023
PeopleSpheres is a Paris-based company that specializes in providing a comprehensive human resources information system (HRIS) software solution designed to meet the diverse needs of businesses. Founded in 2010 and originally named NeoSpheres SAS, the company rebranded to PeopleSpheres in September 2019. The software solution offered by PeopleSpheres is tailored to be suitable, sustainable, and scalable, addressing the specific challenges faced by organizations in HR management. To enhance its offerings, PeopleSpheres collaborates with leading national HR service providers, particularly targeting American businesses. As of September 2019, PeopleSpheres operates as a subsidiary of Sopra HR Software SAS, further solidifying its position in the HR technology space.

Diogenx

Series A in 2023
DiogenX is a preclinical stage biotechnology company based in Marseille, France, with research facilities in Nice. Founded in 2019, it specializes in developing therapeutic solutions for diabetic patients, focusing on pancreatic beta-cell modulators for the treatment of both Type 1 and Type 2 diabetes. The company aims to create a candidate molecule that regenerates pancreatic insulin-producing cells, which could significantly improve the quality of life and survival rates for individuals with diabetes. This innovative approach has the potential to become a groundbreaking therapy for beta-cell regeneration in diabetes management, stemming from research conducted in the laboratory of Dr. Patrick Collombat.

Iktos

Series A in 2023
Iktos is a French scale-up company focused on applying artificial intelligence and robotic technologies to medicinal chemistry and drug design. The company has developed a proprietary generative AI solution that optimizes small molecules in silico, enhancing productivity in pharmaceutical research and development. Iktos offers its expertise through its SaaS platforms, Makya™ for generative drug design and Spaya™ for retrosynthesis, while also collaborating with pharmaceutical companies to accelerate drug discovery processes. Additionally, Iktos has created Iktos Robotics, an AI-driven automation platform that significantly speeds up the Design-Make-Test-Analyze cycle in drug discovery. The company is also advancing its own pipeline of drug candidates aimed at oncology and autoimmune diseases. In 2023, Iktos completed a significant financing round and, in 2024, expanded its capabilities through the acquisition of Synsight, integrating a biology platform focused on discovering new drugs that target Protein-Protein Interactions and RNA-Protein Interactions.

VSORA

Venture Round in 2023
VSORA is an intellectual property provider based in France, specializing in digital signal processing (DSP) technology for semiconductor chips used in advanced digital communications systems, including 5G networks. Founded in 2015 by a team of experienced DSP engineers, the company offers a powerful multi-core DSP architecture that eliminates the need for DSP co-processors, allowing for greater flexibility akin to software programming. VSORA's innovative DSP development flow facilitates collaboration between signal processing and software engineers, significantly accelerating time-to-market for new products. The company focuses on enhancing DSP computing power while optimizing power consumption and performance, ultimately reducing the silicon footprint required for complex integrated circuits.

Opensee

Series A in 2022
Opensee is a Paris-based fintech company that specializes in providing self-service analytics solutions for financial institutions. Founded by a team of experts from the financial and technology sectors, Opensee addresses the challenges posed by big data by enabling organizations to efficiently analyze vast quantities of data on demand. The platform allows business users to perform in-depth analyses and what-if scenarios, facilitating better decision-making in areas such as risk management in capital markets and resource management in commercial and retail banking. By transforming complex data into actionable insights, Opensee empowers financial institutions to enhance their market intelligence and streamline regulatory reporting processes.

Gourmey

Series A in 2022
Gourmey is a pioneering cultivated meat company based in Paris, France, founded in 2019. It specializes in the development and production of ethical foie gras derived from duck cells, aiming to revolutionize the traditional foie gras industry. By utilizing a lab-based approach, Gourmey cultivates meat without the need for force-feeding or slaughter, ensuring a more humane and sustainable alternative. The company places duck cells in a controlled environment, providing optimal temperature, essential nutrients, and space for growth, which results in a product that prioritizes consumer health, environmental sustainability, and animal welfare.

Ternoa

Seed Round in 2022
Ternoa is a technology company based in Biarritz, Nouvelle-Aquitaine, France, specializing in blockchain solutions for secure and anonymous data transfer. Founded in 2013, Ternoa's innovative technology facilitates digital transmission, allowing users to safely store and manage encrypted data through decentralized storage providers. By employing multi-party cryptography, the company ensures the long-term integrity of data, particularly in the context of non-fungible tokens (NFTs). Ternoa's approach eliminates the need for intermediaries, enabling seamless and secure access to digital information for users worldwide.

Qubit Pharmaceuticals

Seed Round in 2022
Qubit Pharmaceuticals is a Paris-based company established in 2020, focusing on innovative technology for pharmaceutical drug discovery. Founded by prominent academic institutions and researchers, including CNAM, CNRS, the University of Texas at Austin, Sorbonne University, and Washington University, the company leverages over 20 years of research and development. Qubit Pharmaceuticals has developed a drug discovery simulation platform that aims to significantly reduce the cost and duration of preclinical drug development. Utilizing proprietary force field models and molecular dynamics calculations, the platform facilitates virtual screening and visualization of potential drug candidates. By integrating principles of quantum physics, Qubit Pharmaceuticals supports biopharmaceutical companies in accelerating their research and development processes, ultimately enhancing the efficiency of drug discovery.

Domain Therapeutics

Series A in 2022
Domain Therapeutics SA is a biopharmaceutical company based in Illkirch-Graffenstaden, France, focused on the discovery and early development of therapeutic drugs targeting G protein-coupled receptors (GPCRs), which are key drug targets in various diseases. Founded in 2001, the company specializes in developing small molecules for the treatment of central nervous system (CNS) disorders and cancer. It employs its proprietary technology platform, DTect-All, which enables the identification of orthosteric and allosteric ligands, including Silent Allosteric Modulators (SAMs) that are challenging to discover using conventional methods. In addition, Domain Therapeutics offers BioSens-All, a platform to explore the signaling complexities associated with GPCR activation, enhancing its ability to address difficult targets, such as orphan and peptidic GPCRs.

TagEnergy

Venture Round in 2022
TagEnergy is a clean energy enterprise for a new cycle in the renewable energy industry. It was formed in 2019 to accelerate the energy transition by developing and investing in competitive and clean power stations in order to compete directly and actively on the energy markets. Renewables have now become the main source of energy able to provide both social responsibility and price efficiency, and we are delivering this in the countries where we have established our activity. ​TagEnergy is operated by a highly-experienced team of manager-shareholders. Its operations span the renewables value chain, from development, financing, construction and asset management of wind, solar and storage projects, to commercialisation of its competitive energy. TagEnergy has developed a portfolio of 2.7GW in the UK, Australia, Spain, Portugal and France, and intends to drive the pace of transition through projects that deliver reliable energy affordably, and at scale.

Unseenlabs

Series B in 2021
Unseenlabs is a French company founded in 2015 and headquartered in Rennes, Brittany, specializing in marine surveillance services. The company designs and develops advanced spectrum surveillance payloads that enable the detection and tracking of non-cooperative vessels worldwide. Unseenlabs offers comprehensive solutions that encompass satellite design, deployment, and operational support. By launching satellites that can detect and geolocate signals and electromagnetic waves emitted by ships, Unseenlabs provides clients with the capability to monitor maritime activities, even when vessels disable their Automatic Identification System beacons. This technology is particularly valuable for identifying illegal operations such as fishing violations, degassing, and maritime piracy.

PeopleSpheres

Venture Round in 2021
PeopleSpheres is a Paris-based company that specializes in providing a comprehensive human resources information system (HRIS) software solution designed to meet the diverse needs of businesses. Founded in 2010 and originally named NeoSpheres SAS, the company rebranded to PeopleSpheres in September 2019. The software solution offered by PeopleSpheres is tailored to be suitable, sustainable, and scalable, addressing the specific challenges faced by organizations in HR management. To enhance its offerings, PeopleSpheres collaborates with leading national HR service providers, particularly targeting American businesses. As of September 2019, PeopleSpheres operates as a subsidiary of Sopra HR Software SAS, further solidifying its position in the HR technology space.

Biosyl

Venture Round in 2020
Biosyl SAS is a holding company based in Cosne-Cours-sur-Loire, France, founded in 2010. It specializes in the production of wood energy and fuel wood pellets, utilizing waste and wood scrap to create low-emission energy solutions. Through its subsidiary, Biosyl operates a pellet production plant capable of processing logs into pellets, achieving an annual production capacity exceeding one hundred thousand tons. This innovative approach not only helps in recovering local coppice wood but also enables customers to reduce their carbon footprint by transforming wood waste into energy with minimal CO2 emissions.

AB Tasty

Series C in 2020
AB Tasty is a software company that specializes in providing a platform for experimentation, personalization, and product optimization aimed at marketing and product teams. Founded in 2009 and headquartered in Paris, France, the company enables businesses across various sectors, including e-commerce, retail, travel, luxury, media, and financial services, to enhance their digital presence. AB Tasty's platform includes tools for A/B testing, multivariate testing, and user engagement, helping organizations convert website and mobile visitors into customers, subscribers, and leads. By leveraging data on online usage, AB Tasty assists teams in creating optimized user experiences that align with their business objectives, ultimately driving increased conversions and revenue across digital channels.

Enterome

Series E in 2020
Enterome SA is a biopharmaceutical company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, Enterome specializes in the development of disease management solutions leveraging the gut microbiome. It focuses on creating biomarkers and therapeutics for microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. The company utilizes its proprietary OncoMimic technology to address cancer treatment by overcoming immune tolerance against tumors, enabling the development of off-the-shelf therapies that prompt a robust immune response. Enterome's innovative drug candidates, which include small proteins and peptides, aim to generate an endogenous CD8 T cell response and are currently advancing through Phase 2 clinical trials for challenging cancers such as glioblastoma and colorectal cancer. The company has formed a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development capabilities.

Biofutur

Acquisition in 2020
Biofutur is a group of medical biology analysis laboratories based primarily in France. The company operates a network of medical laboratories that provide a wide array of services, including medical consultations, hematology, allergology, immunoassays, and embryo transfer. By focusing on diverse medical analyses and related services, Biofutur aims to meet the healthcare needs of its clients while contributing to advancements in medical biology.

TISSIUM

Series B in 2019
TISSIUM is a medical device company headquartered in Paris, France, focused on the development and commercialization of innovative biodegradable sealants and adhesives for surgical wound closure, particularly in minimally invasive procedures. The company's products are designed to be non-toxic, provide strong adhesion to tissues, and enable rapid wound closure in the body's dynamic environments. TISSIUM leverages advanced research and intellectual property from renowned laboratories, including those of Robert Langer at MIT and Jeff Karp at Brigham and Women’s Hospital. Its technology platform includes a proprietary family of fully biosynthetic, biomorphic, and programmable polymers, which are tailored for tissue reconstruction across various clinical applications. Founded in 2013, TISSIUM is supported by leading healthcare investors and aims to address unmet clinical needs through its groundbreaking approach to wound management.

Biosyl

Venture Round in 2019
Biosyl SAS is a holding company based in Cosne-Cours-sur-Loire, France, founded in 2010. It specializes in the production of wood energy and fuel wood pellets, utilizing waste and wood scrap to create low-emission energy solutions. Through its subsidiary, Biosyl operates a pellet production plant capable of processing logs into pellets, achieving an annual production capacity exceeding one hundred thousand tons. This innovative approach not only helps in recovering local coppice wood but also enables customers to reduce their carbon footprint by transforming wood waste into energy with minimal CO2 emissions.

Newronika

Series A in 2019
Newronika is a company dedicated to restoring brain and body functions through innovative neuro-modulation technologies. It translates extensive expertise in biosignal decoding into clinical applications aimed at enhancing treatments, health, and overall wellness. By utilizing a therapeutic device that employs a retro-activity system, Newronika records brain activity and modulates neuro-stimulation to analyze and interpret bio-signals. This technology ensures that patients receive the appropriate stimulation at critical moments, enabling them to engage in normal daily activities and improve their quality of life. Founded as a spin-off from two prominent Italian research institutions, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan, Newronika prides itself on a multidisciplinary team of scientists specializing in various fields, including neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.

Wizaplace

Venture Round in 2019
Wizaplace is a software as a service (SaaS) company based in Lyon, France, that specializes in providing a comprehensive marketplace creation platform. Established in 2012, it offers an all-in-one solution designed to facilitate the development and management of various marketplace models, including B2C, B2B, and C2C projects, as well as services tailored to specific needs. The platform integrates essential functions needed for marketplace operation, featuring a complete back office for administrators and sellers, and an intuitive front office for clients. By enabling customization and providing a user-friendly interface, Wizaplace empowers e-retailers to easily create and manage their online marketplaces within a single cloud-based environment.

Bankin'

Series B in 2019
Bankin' is a mobile application focused on simplifying money management for its users. With a user base of over 1.5 million across France, England, Spain, and Germany, the company prides itself on being the leading independent money management solution in Europe. The app utilizes intelligent algorithms and human coaching to deliver personalized advice related to savings, credit, and insurance, ensuring that customers can manage their finances efficiently. Bankin' emphasizes its commitment to transparency and simplicity, allowing users to concentrate on their priorities without the complications often associated with financial management. By remaining independent of traditional banking institutions, Bankin' aims to provide unbiased guidance tailored to the individual needs of its customers.

NH TherAguix

Series A in 2019
NH TherAguix SAS is a clinical-stage pharmaceutical company based in Villeurbanne, France, focused on the development of nanomedicines for cancer treatment. The company specializes in creating innovative therapeutics that enhance radiotherapy for solid tumors. Its lead product, AGuIX, is a theranostic nanoparticle designed to improve the localization of tumors and optimize radiation therapy outcomes. By facilitating intravenous administration, AGuIX enables healthcare professionals to determine the best timing for irradiation, targets tumor tissues more effectively, and minimizes adverse effects on healthy tissues by reducing radiation doses. Founded in 2015, NH TherAguix is dedicated to advancing cancer treatment through its pioneering approach to combining imaging and radiotherapy.

Teach on Mars

Venture Round in 2019
Teach on Mars SAS is a leading provider of mobile learning technology based in Sophia Antipolis, France, with additional offices in Paris, Milan, and London. Founded in 2013, the company has established itself as a prominent player in the mobile learning sector, delivering solutions to over 100 clients in more than 60 countries and in 20+ languages. The platform enables organizations to create mobile courses and learning games, manage training programs, and analyze learner progress through comprehensive analytics. Teach on Mars offers various applications, including Learn on Mars for personalized learning experiences and Quiz on Mars, which promotes engagement through social learning games. Additionally, the company provides training, certification, and support services, as well as integration and professional content marketplace solutions. With a dedicated team and a global network of partners, Teach on Mars aims to equip organizations with the necessary tools and expertise to develop effective learning ecosystems while committing 1% of its revenues to education initiatives aligned with the UN Sustainable Development Goals.

Sentryo

Series A in 2018
Sentryo SAS is a cybersecurity company that specializes in providing solutions for industrial networks and the Internet of Things. Founded in 2014 and headquartered in Charbonnières-les-Bains, France, Sentryo focuses on ensuring the resilience and safety of industrial operations by offering continuous visibility over Industrial Control Systems (ICS) and SCADA infrastructures. The company's flagship product, ICS CyberVision, enables control engineers to monitor all equipment connected to industrial networks, identify vulnerabilities, and make informed decisions to maintain system integrity. Sentryo's solutions leverage artificial intelligence and machine learning algorithms to deliver real-time insights, detect anomalies, and manage cyber risks effectively. The company serves various sectors, including smart cities, utilities, and energy grids, making it a crucial player in securing critical infrastructures. As of 2019, Sentryo operates as a subsidiary of Cisco Systems, Inc.

Intersec

Venture Round in 2018
Intersec SA, established in 2004, is a global technology company headquartered in Paris, France, with an additional office in London, UK. It specializes in providing streaming analytics solutions to various sectors, including telecommunications, utilities, manufacturing, financial services, and retail. Intersec's offerings encompass customer base management, location data monetization, fraud management, public safety, IoT analytics, and messaging solutions. The company's solutions enable organizations to derive real-time insights from vast amounts of data, helping them to optimize operations, enhance customer experiences, and drive new revenue streams. Intersec serves over 90 clients across 40 countries, reaching nearly one billion connected devices and covering over 400 million people with its mission-critical communication solutions. Recognized by Gartner as a leading vendor in location intelligence and telecom data monetization, Intersec prioritizes privacy and regulatory compliance, ensuring it operates responsibly worldwide.

Antabio

Series A in 2018
Antabio is a private biopharmaceutical company based in Labege, France, focused on developing innovative treatments for drug-resistant infections, particularly targeting critical priority pathogens. Founded in 2009, the company specializes in creating novel antibacterial resistance-breakers, including stand-alone inhibitors of bacterial metalloenzymes. These inhibitors are designed to be combined with existing antibiotics, such as carbapenems, to restore their efficacy against the most challenging pathogens responsible for life-threatening infections, including carbapenem-resistant nosocomial pneumonia. Antabio aims to address significant unmet medical needs in the treatment of drug-resistant infections, ultimately providing healthcare professionals with effective medicinal products to combat these critical health challenges. The company has been recognized for its work, receiving a Wellcome Trust Seeding Drug Discovery Award.

Marquetis

Debt Financing in 2018
Marquetis & Co, founded in 1996 and based in Boulogne Billancourt, France, operates within the French marketing and communications sector. The company provides a comprehensive range of operational marketing services through its subsidiaries, including Marquetis One, Marquetis Connect, and Marquetis Call. Marquetis specializes in relational branding strategies, offering clients services in strategic consulting, creative development, digital marketing, and customer engagement. The firm focuses on delivering automated cross-channel marketing solutions in a Software as a Service (SaaS) format, employing predictive performance models to enhance brand strategies and ensure effective communication. Managed by Virginie Massa and Evangelos Vatzias, Marquetis has established itself as a key player in the marketing landscape, delivering tailored solutions that meet the diverse needs of enterprises.

Tiller Systems

Series B in 2018
Tiller Systems SAS is a Paris-based company that specializes in developing cloud-based point of sale (POS) software solutions for restaurants and merchants. Founded in March 2014, Tiller's management tools enable users to accept various payment types, integrate partner applications, and effectively oversee staff and inventory in real time. The software features a mobile POS system that allows for the management of both in-store and online orders from a single platform. Additionally, Tiller offers a web dashboard that facilitates catalog updates, sales tracking, employee payments, stock alerts, customer relationship management, and access to real-time reporting and performance metrics. With additional offices in Barcelona and Milan, Tiller Systems aims to empower businesses to make informed decisions and enhance their operational efficiency.

Nanomakers

Venture Round in 2018
S.A. Nanomakers is a Paris-based company established in 2010 that focuses on the design, manufacturing, and marketing of silicon-based nanomaterials, particularly nanopowders. These patented, nano-scale powders serve to significantly enhance the mechanical, thermal, and chemical properties of various industrial materials, including metal alloys and elastomers. Nanomakers' silicon carbide and silicon nanopowders play a crucial role in advancing sectors such as semiconductors, energy storage, aerospace, and automotive. The company's innovative materials double the energy storage density of lithium-ion batteries by utilizing nano-composites, thereby positioning Nanomakers at the forefront of technology that drives performance improvements across multiple industries.

VSORA

Series A in 2018
VSORA is an intellectual property provider based in France, specializing in digital signal processing (DSP) technology for semiconductor chips used in advanced digital communications systems, including 5G networks. Founded in 2015 by a team of experienced DSP engineers, the company offers a powerful multi-core DSP architecture that eliminates the need for DSP co-processors, allowing for greater flexibility akin to software programming. VSORA's innovative DSP development flow facilitates collaboration between signal processing and software engineers, significantly accelerating time-to-market for new products. The company focuses on enhancing DSP computing power while optimizing power consumption and performance, ultimately reducing the silicon footprint required for complex integrated circuits.

Enterome

Debt Financing in 2018
Enterome SA is a biopharmaceutical company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, Enterome specializes in the development of disease management solutions leveraging the gut microbiome. It focuses on creating biomarkers and therapeutics for microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. The company utilizes its proprietary OncoMimic technology to address cancer treatment by overcoming immune tolerance against tumors, enabling the development of off-the-shelf therapies that prompt a robust immune response. Enterome's innovative drug candidates, which include small proteins and peptides, aim to generate an endogenous CD8 T cell response and are currently advancing through Phase 2 clinical trials for challenging cancers such as glioblastoma and colorectal cancer. The company has formed a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development capabilities.

AB Tasty

Series B in 2017
AB Tasty is a software company that specializes in providing a platform for experimentation, personalization, and product optimization aimed at marketing and product teams. Founded in 2009 and headquartered in Paris, France, the company enables businesses across various sectors, including e-commerce, retail, travel, luxury, media, and financial services, to enhance their digital presence. AB Tasty's platform includes tools for A/B testing, multivariate testing, and user engagement, helping organizations convert website and mobile visitors into customers, subscribers, and leads. By leveraging data on online usage, AB Tasty assists teams in creating optimized user experiences that align with their business objectives, ultimately driving increased conversions and revenue across digital channels.

RGF GROUP

Acquisition in 2017
RGF Group is a manufacturer specializing in plastic injection molding, catering to various sectors such as healthcare, sports, construction, home automation, automotive, and industrial equipment. The company utilizes advanced technology, including electric and hydraulic machines, to offer both single and bi-material injection solutions. In addition to manufacturing, RGF Group provides expertise in the design and production of injection tooling, ensuring high-quality and efficient service. With production facilities located in France and globally, RGF Group emphasizes flexibility and responsiveness to meet the industrial challenges of its clients.

MultiX

Venture Round in 2017
MultiX S.A., founded in 2010 and headquartered in Neuilly-sur-Seine, France, specializes in designing, producing, and selling spectrometric X-ray detectors. These detectors are used for material identification in various applications including security, food processing, mining, recycling, industry, and non-destructive testing. MultiX's advanced multi-energy technology is particularly beneficial for reducing false alarms in baggage screening systems at airports and sensitive infrastructure, thereby enhancing passenger facilitation and experience by minimizing the need to remove liquids and laptops from hand baggage while adhering to stringent security regulations. The company supplies system manufacturers with this technology, enabling them to improve operational efficiency and meet regulatory standards across multiple industries.

Bankin'

Series A in 2017
Bankin' is a mobile application focused on simplifying money management for its users. With a user base of over 1.5 million across France, England, Spain, and Germany, the company prides itself on being the leading independent money management solution in Europe. The app utilizes intelligent algorithms and human coaching to deliver personalized advice related to savings, credit, and insurance, ensuring that customers can manage their finances efficiently. Bankin' emphasizes its commitment to transparency and simplicity, allowing users to concentrate on their priorities without the complications often associated with financial management. By remaining independent of traditional banking institutions, Bankin' aims to provide unbiased guidance tailored to the individual needs of its customers.

Enterome

Series D in 2017
Enterome SA is a biopharmaceutical company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, Enterome specializes in the development of disease management solutions leveraging the gut microbiome. It focuses on creating biomarkers and therapeutics for microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. The company utilizes its proprietary OncoMimic technology to address cancer treatment by overcoming immune tolerance against tumors, enabling the development of off-the-shelf therapies that prompt a robust immune response. Enterome's innovative drug candidates, which include small proteins and peptides, aim to generate an endogenous CD8 T cell response and are currently advancing through Phase 2 clinical trials for challenging cancers such as glioblastoma and colorectal cancer. The company has formed a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development capabilities.

Enterome

Series C in 2016
Enterome SA is a biopharmaceutical company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, Enterome specializes in the development of disease management solutions leveraging the gut microbiome. It focuses on creating biomarkers and therapeutics for microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. The company utilizes its proprietary OncoMimic technology to address cancer treatment by overcoming immune tolerance against tumors, enabling the development of off-the-shelf therapies that prompt a robust immune response. Enterome's innovative drug candidates, which include small proteins and peptides, aim to generate an endogenous CD8 T cell response and are currently advancing through Phase 2 clinical trials for challenging cancers such as glioblastoma and colorectal cancer. The company has formed a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development capabilities.

TISSIUM

Series A in 2016
TISSIUM is a medical device company headquartered in Paris, France, focused on the development and commercialization of innovative biodegradable sealants and adhesives for surgical wound closure, particularly in minimally invasive procedures. The company's products are designed to be non-toxic, provide strong adhesion to tissues, and enable rapid wound closure in the body's dynamic environments. TISSIUM leverages advanced research and intellectual property from renowned laboratories, including those of Robert Langer at MIT and Jeff Karp at Brigham and Women’s Hospital. Its technology platform includes a proprietary family of fully biosynthetic, biomorphic, and programmable polymers, which are tailored for tissue reconstruction across various clinical applications. Founded in 2013, TISSIUM is supported by leading healthcare investors and aims to address unmet clinical needs through its groundbreaking approach to wound management.

Intersec

Series C in 2016
Intersec SA, established in 2004, is a global technology company headquartered in Paris, France, with an additional office in London, UK. It specializes in providing streaming analytics solutions to various sectors, including telecommunications, utilities, manufacturing, financial services, and retail. Intersec's offerings encompass customer base management, location data monetization, fraud management, public safety, IoT analytics, and messaging solutions. The company's solutions enable organizations to derive real-time insights from vast amounts of data, helping them to optimize operations, enhance customer experiences, and drive new revenue streams. Intersec serves over 90 clients across 40 countries, reaching nearly one billion connected devices and covering over 400 million people with its mission-critical communication solutions. Recognized by Gartner as a leading vendor in location intelligence and telecom data monetization, Intersec prioritizes privacy and regulatory compliance, ensuring it operates responsibly worldwide.

AB Tasty

Series A in 2016
AB Tasty is a software company that specializes in providing a platform for experimentation, personalization, and product optimization aimed at marketing and product teams. Founded in 2009 and headquartered in Paris, France, the company enables businesses across various sectors, including e-commerce, retail, travel, luxury, media, and financial services, to enhance their digital presence. AB Tasty's platform includes tools for A/B testing, multivariate testing, and user engagement, helping organizations convert website and mobile visitors into customers, subscribers, and leads. By leveraging data on online usage, AB Tasty assists teams in creating optimized user experiences that align with their business objectives, ultimately driving increased conversions and revenue across digital channels.

Dispam

Venture Round in 2015
Dispam is a transportation and logistics company based in Vedene, France, founded in 1971. The company specializes in temperature-controlled transportation, particularly for fresh produce, as well as general cargo. In addition to its core transportation services, Dispam offers complementary logistics solutions, providing a comprehensive range of high value-added services tailored to meet the needs of its clients.

Capcom Groupe

Venture Round in 2015
Capcom Groupe SARL is a telecommunications services provider based in Marly, France, specializing in the deployment, installation, and technical maintenance of fiber optic networks. Established in 2001, the company focuses on serving telecom operators by delivering comprehensive solutions for fiber optic and cable network services. As of 2017, Capcom Groupe operates as a subsidiary of Groupe Circet S.A., enhancing its capabilities in the telecommunications sector.

The Luneau Technology Group

Private Equity Round in 2015
The Luneau Technology Group, based in Pont-de-l'Arche, France, develops, manufactures, and markets a comprehensive range of refraction and diagnostic instruments tailored for optometrists, ophthalmologists, and other vision care practitioners. With a history dating back to 1926, the company encompasses the Briot and Weco brands alongside Visionix, offering solutions that include edging systems and industrial equipment for opticians, laboratories, and central workshops. Its product portfolio addresses various needs within the vision correction process, from refraction and ophthalmic diagnosis to lens inspection and finishing. Luneau Technology Group aims to enhance the screening process for visual disorders and improve patient quality of life by providing innovative technologies. The company maintains a strong global presence through a network of seven subsidiaries and over 130 dealers, ensuring alignment with customer needs and market demands.

Annonay Productions France

Acquisition in 2014
Annonay Productions France S.A. specializes in the design, manufacture, and distribution of swimming pool equipment. Established in 1995 and headquartered in Annonay, France, the company is recognized as a leader in its sector, producing a range of products including liners, summer and winter covers, and automatic shutters. In addition to these offerings, Annonay Productions France provides roller mechanisms, AlkorPlan PVC materials, isothermal safety covers, and aluminum bar safety covers. The company also supplies various components such as liner sheets, bubble wrap, PVC coated fabric, rigid PVC slats, and drive units, catering to the diverse needs of the swimming pool industry.

Enterome

Series B in 2014
Enterome SA is a biopharmaceutical company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, Enterome specializes in the development of disease management solutions leveraging the gut microbiome. It focuses on creating biomarkers and therapeutics for microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. The company utilizes its proprietary OncoMimic technology to address cancer treatment by overcoming immune tolerance against tumors, enabling the development of off-the-shelf therapies that prompt a robust immune response. Enterome's innovative drug candidates, which include small proteins and peptides, aim to generate an endogenous CD8 T cell response and are currently advancing through Phase 2 clinical trials for challenging cancers such as glioblastoma and colorectal cancer. The company has formed a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development capabilities.

TISSIUM

Series A in 2013
TISSIUM is a medical device company headquartered in Paris, France, focused on the development and commercialization of innovative biodegradable sealants and adhesives for surgical wound closure, particularly in minimally invasive procedures. The company's products are designed to be non-toxic, provide strong adhesion to tissues, and enable rapid wound closure in the body's dynamic environments. TISSIUM leverages advanced research and intellectual property from renowned laboratories, including those of Robert Langer at MIT and Jeff Karp at Brigham and Women’s Hospital. Its technology platform includes a proprietary family of fully biosynthetic, biomorphic, and programmable polymers, which are tailored for tissue reconstruction across various clinical applications. Founded in 2013, TISSIUM is supported by leading healthcare investors and aims to address unmet clinical needs through its groundbreaking approach to wound management.

Pixium Vision

Series A in 2013
Pixium Vision SA is a bioelectronics company based in Paris, France, focused on developing innovative implantable medical devices aimed at restoring vision for individuals blinded by the degeneration of photoreceptor cells in the retina. The company’s flagship product, the PRIMA System, is a bionic vision system designed to improve visual acuity and enhance the independence of patients. Pixium Vision also works on the Intelligent Retinal Implantable System (IRIS1), which is currently undergoing clinical trials, and is developing two subsequent generations, IRIS2 and IRIS3, each designed to provide improved visual capabilities through advanced technologies. Founded in 2011 as a spin-out from the Vision Institute and Université Pierre et Marie Curie, Pixium collaborates with prestigious institutions such as Stanford University and Moorfields Eye Hospital to further its research and development efforts in retinal implant systems.

Camerus

Acquisition in 2013
Camerus is a furniture rental company based in Gonesse, France, specializing in providing a wide range of furniture for large-scale events such as trade fairs, congresses, and exhibitions. The company offers an extensive selection of rental items, including chairs, armchairs, lounges, tables, desks, display units, and multimedia systems. In addition to standard furniture, Camerus also provides specialized items like floral-décor systems and accessories, catering to the diverse needs of decorators, event agencies, and organizers. Through its comprehensive service offerings, Camerus supports the successful execution of various events by supplying high-quality and aesthetically pleasing furniture solutions.

AT Internet

Venture Round in 2013
AT Internet is one of the French Internet’s early pioneers. After two decades of existence, AT Internet is the only European company today among the worldwide leaders in digital analytics and digital intelligence. AT Internet’s Analytics Suite is used on more than 20,000 websites, mobile sites, and mobile apps globally. We count amongst our customers some of the world’s largest media groups (BBC, NPO, Schibsted, RTE, Le Monde…), banks (AXA, Société Générale, Crédit Agricole…) and have partnered with certain clients for more than a decade. Our unique approach to digital analytics is different from other solutions on the market. Having data you can trust is a mandatory foundation for any analytics project you undertake. That’s why our Analytics Suite features tools for easy quality control and dependable tagging for fully reliable data. Our solution and processes are completely compliant with stringent privacy laws (notably the European GDPR) and are certified by third-party auditors worldwide.

SuperSonic Imagine

Private Equity Round in 2013
SuperSonic Imagine SA is a medical technology company based in Aix-en-Provence, France, specializing in the development and manufacture of ultrasound imaging systems. Founded in 2005, the company is recognized for its Aixplorer system, which delivers high-definition, high-contrast imaging crucial for diagnosing and monitoring various conditions, including breast, prostate, and thyroid cancers, as well as liver diseases. SuperSonic Imagine also offers the ShearWave technology platform, which focuses on quantitative elastography for assessing tissue elasticity. The company operates primarily in France, the United States, and China, and distributes its products through a network of offices and partners across various countries, including Belgium, Germany, and the United Kingdom. As a subsidiary of Hologic Hub Ltd, SuperSonic Imagine continues to innovate in the field of medical imaging technology, enhancing the capabilities of healthcare practitioners.

Futuris SPA

Venture Round in 2013
Futuris SpA, founded in 2009 and headquartered in Milan, Italy, specializes in the development and acquisition of projects utilizing agro-forestry biomass and vegetable oils. The company focuses on investing in the construction of energy generation and cogeneration plants that produce both electricity and heat. By leveraging sustainable resources, Futuris SpA aims to contribute to the renewable energy sector and promote environmentally friendly energy solutions.

Poxel

Series B in 2012
Poxel is a biopharmaceutical company based in Lyon, France, focused on developing innovative drugs for metabolic diseases, with a primary emphasis on type 2 diabetes and non-alcoholic steatohepatitis (NASH). Founded in 2009, Poxel's lead product is Imeglimin, an oral anti-diabetic candidate in Phase III clinical development that targets key organs affected by diabetes, such as the pancreas, liver, and muscles. The company is also advancing PXL770, an adenosine monophosphate-activated protein kinase enzyme in Phase IIa clinical trials for treating chronic metabolic diseases like NASH. Additionally, Poxel has licensing agreements for PXL007 (EYP001), an FXR agonist in Phase I study for hepatitis B and NASH, and PXL065, a mitochondrial pyruvate carrier inhibitor in Phase I clinical trials for NASH.

Greenbureau

Seed Round in 2012
Greenbureau SA is a Paris-based company founded in 2011 that operates an online platform designed to enhance personal finance management and streamline customer interactions. The platform centralizes invoices and statements from major suppliers and public services in France, allowing users to automatically retrieve their financial documents and manage them through a single login. In addition to digital billing and invoicing, Greenbureau offers services such as Zen Call, Zen Care, and Call Bot, which are designed to improve customer communication and reduce waiting times. By facilitating budgeting, providing time and alert options, and offering unlimited storage, Greenbureau aims to simplify the customer experience while helping businesses reduce management costs through increased digital engagement. The company generates revenue through partnerships with major providers, allowing it to offer its services free of charge to users.

Adictiz

Venture Round in 2012
Adictiz is a French company, founded in 2009 by Charles Christory, that specializes in developing and publishing social games for web and mobile platforms. Based in Lille at the EuraTechnologies hub, Adictiz has gained recognition for popular titles such as "Space Dog" and "What a Stupid Pigeon," which collectively attract around 2.5 million players monthly. The company also operates Adictiz Studio, established in 2011, which focuses on creating customized social games tailored for brands. This studio integrates graphic designs, videos, texts, and images into game interfaces, enabling advertisers to utilize these games as effective marketing tools while tracking engagement and conversion metrics. Adictiz's innovative approach has positioned it as a leader in the social and mobile gaming industry.

Mister Bell

Series A in 2012
Mister Bell is a digital advertising firm based in Paris, France, specializing in mobile advertising solutions across Europe. Founded in 2010, the company focuses on maximizing return on investment for advertisers while offering comprehensive monetization solutions for publishers. Its service offerings include mobile acquisition solutions, mobile tracking, ad serving, campaign optimization, and geo-location advertising, as well as detailed real-time reporting. In addition to these services, Mister Bell provides a suite of software tools that enhance its advertising capabilities, including filtering, clustering, targeting, retargeting, and brand safety measures. Through its innovative approach, Mister Bell effectively supports clients in navigating the complexities of mobile advertising.

Ividence

Series B in 2012
Ividence, Inc. is an email advertising platform that connects advertisers with publishers to optimize email marketing campaigns. Founded in 2008 and headquartered in Paris, France, with additional offices in New York and San Francisco, Ividence offers a comprehensive email advertising exchange platform. This platform utilizes behavioral targeting technology to deliver tailored advertising content to specific audiences, enhancing the effectiveness of email campaigns. Ividence also focuses on maintaining list hygiene and managing user feedback, including unsubscribe requests and complaints. By providing real-time reporting and CRM retargeting capabilities, the company enables advertisers to optimize their campaigns for lead generation and customer conversion while allowing publishers to monetize their newsletters effectively.

Eptica

Venture Round in 2012
Eptica S.A. is a company that specializes in designing and developing customer relationship management (CRM) software for business-to-business marketplaces. Founded in 2001 and headquartered in Boulogne-Billancourt, France, Eptica offers solutions that facilitate real-time interactions between enterprises, clients, suppliers, and partners through multiple digital channels. Its software includes features for social customer service, email management, chat, and knowledge management, enabling organizations to enhance customer engagement and drive sales through personalized communication. Additionally, Eptica provides professional services such as technical support, training, and consulting, catering to various sectors including banking, insurance, retail, tourism, and public institutions. As of October 2019, Eptica operates as a subsidiary of Enghouse Systems Limited.

Enterome

Series A in 2012
Enterome SA is a biopharmaceutical company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, Enterome specializes in the development of disease management solutions leveraging the gut microbiome. It focuses on creating biomarkers and therapeutics for microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. The company utilizes its proprietary OncoMimic technology to address cancer treatment by overcoming immune tolerance against tumors, enabling the development of off-the-shelf therapies that prompt a robust immune response. Enterome's innovative drug candidates, which include small proteins and peptides, aim to generate an endogenous CD8 T cell response and are currently advancing through Phase 2 clinical trials for challenging cancers such as glioblastoma and colorectal cancer. The company has formed a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development capabilities.

AEMI Group

Venture Round in 2012
The AEMI group is one of France’s top high-speed precision machining specialists for mechanical parts and the integration of mechanical and mechanical engineering sub-assemblies. The group manufactures complex and large components in small and medium production runs for high value-added niche markets, especially in the military, aerospace, space and medical equipment sectors.

Viavoo

Series A in 2011
Viavoo is a company based in Boulogne-Billancourt, France, specializing in sentiment and text analytics software aimed at enhancing customer feedback. The firm develops technology that utilizes natural language processing to provide real-time analysis of consumer sentiments, enabling organizations to better understand customer experiences both online and at the point of sale. By leveraging customer voices, Viavoo's software assists businesses in optimizing their marketing strategies, ultimately leading to improved customer experiences and increased profitability.

SpineGuard

Series B in 2011
SpineGuard is a French medical company focused on the design and production of innovative instruments for spinal surgeries, utilizing its proprietary Dynamic Surgical Guidance (DSG®) technology. This powerful, radiation-free sensing platform enhances the accuracy and safety of skeletal implant placement through real-time audio and visual feedback for surgeons. The company's flagship product, the PediGuard probe, is specifically designed for spine surgery, allowing surgeons to create pilot holes in vertebrae with precision. Equipped with a sensor that measures electrical conductivity, the PediGuard alerts surgeons to changes in bone and tissue types without the need for X-ray imaging. Available in various shapes and sizes, these devices cater to a wide range of surgical needs, from pediatric deformity corrections to adult degenerative conditions. With over 80,000 successful spinal procedures supported by PediGuard and substantial clinical evidence backing its efficacy, SpineGuard aims to address critical challenges in pedicle screw placement while improving patient outcomes and operational efficiency in the surgical environment.

Daltys

Private Equity Round in 2011
Daltys SA is a leading operator of vending machines in France, specializing in the marketing and operation of machines for hot and cold beverages, snacks, sandwiches, and sweets. Founded in 1980 and based in Gardanne, the company has an extensive installed base of 55,000 vending machines, serving over 18,000 customers across various sectors, including hospitality, healthcare, education, and public spaces. In addition to vending machines, Daltys develops coffee-shop and multi-service catering concepts, enhancing customer experiences in various environments. The company also offers remote sales management and troubleshooting services, ensuring efficient operation and customer satisfaction.

Aldebaran Robotics

Series C in 2011
Aldebaran Robotics, established in 2005 and headquartered in Paris, France, specializes in the design, manufacture, and sale of autonomous humanoid robots. Their product portfolio includes NAO, a 58-cm tall companion robot capable of moving, recognizing, hearing, and speaking to humans; Pepper, a social robot that engages in conversation, recognizes individuals, responds to emotions, and navigates autonomously; and Romeo, a 140-cm humanoid robot designed for research into assistance for the elderly and those with mobility challenges, featuring advanced capabilities such as door opening, stair climbing, and object manipulation. The company's robots are employed in entertainment, reception, assistance, home care, and autism therapy applications.

Olly Gan

Acquisition in 2011
Olly Gan is a retailer specializing in ready-to-wear clothing and accessories for men, headquartered in Aix-en-Provence. The company operates 138 stores, with 101 functioning as direct branches and the remaining on a commission-based affiliation model. Olly Gan's product range includes a variety of men's apparel, such as jackets, shirts, jeans, and sportswear, along with a selection of accessories, including belts, cufflinks, socks, ties, scarves, and innerwear. The brand aims to provide stylish and functional options for men's fashion.

Ikaros Solar

Private Equity Round in 2011
Ikaros Solar is an international leader in the photovoltaic market, with operational companies in Belgium, the Netherlands, the United Kingdom, Portugal, India, and Mexico. The company specializes in providing solar photovoltaic engineering, procurement, and construction services across various regions, including Benelux, France, and the UK. Ikaros Solar focuses on the installation of turnkey photovoltaic solutions for business clients and specialized investors, catering to both rooftop and ground-mounted solar power plants. Additionally, the company distributes high-quality products to installation contractors, supporting the broader solar energy industry.

SuperSonic Imagine

Series C in 2010
SuperSonic Imagine SA is a medical technology company based in Aix-en-Provence, France, specializing in the development and manufacture of ultrasound imaging systems. Founded in 2005, the company is recognized for its Aixplorer system, which delivers high-definition, high-contrast imaging crucial for diagnosing and monitoring various conditions, including breast, prostate, and thyroid cancers, as well as liver diseases. SuperSonic Imagine also offers the ShearWave technology platform, which focuses on quantitative elastography for assessing tissue elasticity. The company operates primarily in France, the United States, and China, and distributes its products through a network of offices and partners across various countries, including Belgium, Germany, and the United Kingdom. As a subsidiary of Hologic Hub Ltd, SuperSonic Imagine continues to innovate in the field of medical imaging technology, enhancing the capabilities of healthcare practitioners.

Neoen

Private Equity Round in 2010
Neoen is an independent French energy company specializing in the development, financing, construction, and operation of renewable energy power plants. The company operates various types of facilities, including solar, wind, and biomass plants, and has a notable presence in France, Portugal, Australia, Mexico, Egypt, and El Salvador. As of the end of 2022, Neoen had an operational capacity of 5 GW, with a diverse portfolio comprising 54% solar energy, 35% onshore wind, and 11% utility-scale batteries. The company also engages in developing marine renewable energy projects in France and provides support to photovoltaic project developers and investors in the design, construction, operation, and maintenance of solar power plants both domestically and internationally. Neoen's strategic focus on renewable energy underscores its commitment to sustainable power generation.

ConfortVisuel

Venture Round in 2010
ConfortVisuel is an online retailer specializing in optical products, catering to a diverse clientele with a broad range of offerings. With five years of experience and a customer base of 12,000, the company has established itself as a significant player in the market. Its website is designed for smooth navigation, emphasizing user experience. ConfortVisuel provides economical optical products that are tested and adaptable to individual sight requirements. Additionally, the company offers a rental service, allowing visually impaired customers to test and adapt visual aids before making a purchase. Unique to ConfortVisuel is its ability to facilitate third-party online payments and the presence of a showroom in Paris, enhancing customer convenience and engagement.

Poxel

Series A in 2010
Poxel is a biopharmaceutical company based in Lyon, France, focused on developing innovative drugs for metabolic diseases, with a primary emphasis on type 2 diabetes and non-alcoholic steatohepatitis (NASH). Founded in 2009, Poxel's lead product is Imeglimin, an oral anti-diabetic candidate in Phase III clinical development that targets key organs affected by diabetes, such as the pancreas, liver, and muscles. The company is also advancing PXL770, an adenosine monophosphate-activated protein kinase enzyme in Phase IIa clinical trials for treating chronic metabolic diseases like NASH. Additionally, Poxel has licensing agreements for PXL007 (EYP001), an FXR agonist in Phase I study for hepatitis B and NASH, and PXL065, a mitochondrial pyruvate carrier inhibitor in Phase I clinical trials for NASH.

MediaKind

Debt Financing in 2009
MediaKind, headquartered in Frisco, Texas, specializes in media technology. It develops and provides solutions such as media platforms, video decoding, processing, and storage, along with management and control software. The company offers two key platforms: Mediaroom, an IPTV platform, and MediaFirst, a cloud-based TV platform. Additionally, it provides solutions in video processing, stream management, and advertising. MediaKind serves global telecommunications, cable, satellite, and media companies, enabling them to deliver engaging video content across various devices and networks.

Aquafadas

Series A in 2009
Aquafadas specializes in digital publishing technology that facilitates the creation and distribution of interactive digital content, including magazines, newspapers, corporate documents, books, and comics, across various platforms such as smartphones, tablets, and the web. The company provides tailored content creation and distribution solutions, helping businesses enhance their digital publishing strategies while reducing costs. Its client roster includes notable names like Lagardère, Mondadori, and Vodafone. Aquafadas is also recognized for its role in advancing digital publishing standards through memberships in organizations like the International Digital Publishing Forum and IdeAlliance. As part of the Rakuten group, it also contributes its expertise to Kobo, a leading e-reader provider. With offices in Montpellier, Paris, and New York, Aquafadas continues to develop innovative tools and applications for mobile-first audiences, focusing on improving engagement and efficiency for its clients.

SpineGuard

Series A in 2009
SpineGuard is a French medical company focused on the design and production of innovative instruments for spinal surgeries, utilizing its proprietary Dynamic Surgical Guidance (DSG®) technology. This powerful, radiation-free sensing platform enhances the accuracy and safety of skeletal implant placement through real-time audio and visual feedback for surgeons. The company's flagship product, the PediGuard probe, is specifically designed for spine surgery, allowing surgeons to create pilot holes in vertebrae with precision. Equipped with a sensor that measures electrical conductivity, the PediGuard alerts surgeons to changes in bone and tissue types without the need for X-ray imaging. Available in various shapes and sizes, these devices cater to a wide range of surgical needs, from pediatric deformity corrections to adult degenerative conditions. With over 80,000 successful spinal procedures supported by PediGuard and substantial clinical evidence backing its efficacy, SpineGuard aims to address critical challenges in pedicle screw placement while improving patient outcomes and operational efficiency in the surgical environment.

ABC Distribution

Private Equity Round in 2009
ABC Distribution S.A.S. is a French company specializing in the distribution and sale of personal and beauty products. Established in 2001 and headquartered in Bonneuil-sur-Marne, France, the company operates subsidiaries in Hong Kong, Warsaw, Poland, and Barcelona, Spain. ABC Distribution offers a wide range of beauty accessories, including brushes, combs, creams, varnishes, and makeup products, catering to both men and women. The company has achieved significant growth by partnering with internationally recognized brands, such as Elite models, Franck Provost, Berangé, and Princesse Lili. By focusing on smart and glamorous items at competitive prices, ABC Distribution has revitalized the beauty accessories and makeup market in France, increasingly emphasizing products labeled as Made in France.

SuperSonic Imagine

Series B in 2008
SuperSonic Imagine SA is a medical technology company based in Aix-en-Provence, France, specializing in the development and manufacture of ultrasound imaging systems. Founded in 2005, the company is recognized for its Aixplorer system, which delivers high-definition, high-contrast imaging crucial for diagnosing and monitoring various conditions, including breast, prostate, and thyroid cancers, as well as liver diseases. SuperSonic Imagine also offers the ShearWave technology platform, which focuses on quantitative elastography for assessing tissue elasticity. The company operates primarily in France, the United States, and China, and distributes its products through a network of offices and partners across various countries, including Belgium, Germany, and the United Kingdom. As a subsidiary of Hologic Hub Ltd, SuperSonic Imagine continues to innovate in the field of medical imaging technology, enhancing the capabilities of healthcare practitioners.

Urbasolar

Venture Round in 2008
Urbasolar SAS, founded in 2006 and based in Pérols, France, specializes in the design, construction, and operation of photovoltaic power plants across Europe. The company focuses on a wide range of installations, including solar arrays on public, industrial, commercial, and residential buildings, as well as ground-mounted systems and parking canopies. Urbasolar offers a comprehensive turn-key service that encompasses all aspects of project execution, from initial studies and design to administrative and legal procedures, project financing, construction, and ongoing operation and maintenance. As of July 2019, Urbasolar operates as a subsidiary of Axpo Holding AG.

MediaKind

Venture Round in 2008
MediaKind, headquartered in Frisco, Texas, specializes in media technology. It develops and provides solutions such as media platforms, video decoding, processing, and storage, along with management and control software. The company offers two key platforms: Mediaroom, an IPTV platform, and MediaFirst, a cloud-based TV platform. Additionally, it provides solutions in video processing, stream management, and advertising. MediaKind serves global telecommunications, cable, satellite, and media companies, enabling them to deliver engaging video content across various devices and networks.

Ariane Systems

Venture Round in 2008
Ariane Systems Group is a technology company specializing in self-service check-in and check-out solutions for the hospitality industry. Founded in 1994 and headquartered in Pantin, France, the company provides electronic kiosks, mobile applications, and web-based solutions designed to enhance the guest experience by streamlining check-in and check-out processes. Its offerings include features such as passport scanning, image capture, and online registration, allowing guests to bypass the front desk and use their devices for a more efficient experience. Ariane Systems also offers project management, training, and support services to its clients. The company serves a diverse customer base through a network of distributors across Europe, North America, Southeastern Asia, and South Africa, and has established strategic partnerships with notable entities in the industry. Regional offices in the United Kingdom, Germany, Spain, the Benelux, Scandinavia, the Middle East, and North America further bolster its international presence.

Fondis Electronic

Acquisition in 2008
Fondis Bioritech is a group that designs and distributes innovative scientific instrumentation solutions. Founded in 1982, the Group is a leader in portable instrumentation. The group covers several markets: Benelux, Switzerland, Spain, Portugal and Maghreb countries.

SLG Recycling

Acquisition in 2008
SLG Recycling is a company based in Tours, France, that specializes in the recycling of ferrous and non-ferrous metals, as well as the processing of waste. Founded in 1947, the company was originally known as Sepchat S.A. before changing its name to SLG Recycling SA in October 2008. In addition to metal recycling, SLG Recycling offers services such as waste management, collection, sorting, reclamation, and demolition of buildings and structures. As of January 11, 2016, the company operates as a subsidiary of Derichebourg Environnement SAS.

Grain D'Or Gel-Grain D'Or Frais

Private Equity Round in 2008
Grain D'Or Gel-Grain D'Or Frais is one of the first industrial groups to manufacture raw frozen bread. Founded by a Northern France artisan baker in 1965, Grain d’Or Gel was one of the first industrial bakers to manufacture raw frozen dough while preserving the bread’s genuine character.

Valorem

Venture Round in 2007
Valorem is a French company based in Bègles, specializing in the development and operation of renewable energy projects. Established in 1994, it aims to promote sustainable alternatives to fossil fuels by harnessing renewable energy resources across various territories. Valorem manages the entire lifecycle of renewable energy projects, offering services that encompass project management, construction, and auditing. This comprehensive approach supports clients in their efforts to achieve an integrated energy transition, positioning Valorem as a key player in the renewable energy sector.

DiBcom

Series E in 2007
DiBcom S.A., a fabless semiconductor company, offers a range of integrated circuits in France & internationally. It specializes in the development of broadband wireless solutions following digital video broadcasting and other broadband communication standards. The company offers chipsets and development kits. Its solutions are used in automotive, portable LCD TV, PC, mobile phones and other handheld device applications. DiBcom S.A. was founded in 2000 and is headquartered in Palaiseau, France.

Legoupil Industrie

Acquisition in 2007
Legoupil Industrie S.A.S. is a French company specializing in the rental and sale of demountable industrial buildings and modular construction solutions. Established in 1976 and headquartered in Vire, France, the company designs and installs a range of temporary structures, including storage warehouses, logistics platforms, production workshops, and commercial buildings. These structures serve to enhance and expand existing infrastructure, meeting various logistical and operational needs. Legoupil Industrie operates primarily throughout France but also caters to international requests, providing flexible space solutions for both short-term and long-term use. As a subsidiary of the Treuil Group, the company has established itself as a key player in the industrial building rental market in Europe.

OCEAN SAS

Private Equity Round in 2007
OCEAN SAS, founded in 2003 and headquartered in Clichy, France, specializes in providing vehicle tracking solutions. The company offers fleet management services, monitoring and controlling the on-the-road activities of its clients. OCEAN's vehicle tracking system provides real-time information about vehicles and their drivers. Additionally, it customizes management solutions to meet specific client needs, including integration with personal digital assistants, in-car printers, WAP access, vehicle neutralization, driver identification keys, data transfer, and tailored applications.

Sparus Software

Series B in 2007
Sparus Software is a Paris-based independent software vendor specializing in mobile device management solutions. The company designs and develops the EveryWAN Mobility Manager, a comprehensive software suite that allows enterprises to effectively deploy and manage mobile handheld devices over various wireless networks, including GPRS, Edge, 3G, and WiFi. By streamlining the management of mobile devices, Sparus Software helps organizations reduce operating expenses while enhancing operational efficiency.

Idylis

Series B in 2007
Idylis S.A., established in 2008 and headquartered in Issy-les-Moulineaux, France, specializes in designing, developing, and marketing software solutions tailored for enterprise management. The company's product suite supports a range of applications including audit and accounting, financial management, documentation, e-mailing, scheduling, supply chain management, logistics, and inventory management. Additionally, Idylis offers customer support and consulting services to enhance the effectiveness of its software solutions for clients.

Pommier

Acquisition in 2007
Pommier S.A.S. is a manufacturer and distributor of equipment and accessories for industrial vehicles, including trucks and semi-trailers. Established in 1945 and headquartered in Saint-Ouen-l'Aumône, France, the company offers a diverse range of products, such as structural components, interior fittings, lighting, and safety equipment tailored for various vehicle types. Pommier also provides OEM solutions through drop forged, plastic injection, stainless steel, and machined products, serving sectors like agriculture, military, and public works. Additionally, the company manufactures dock and loading bay equipment, including docking buffers and loading bridges, for logistics and storage applications. With production facilities in Normandy, Ardennes, and Isère in France, as well as in Reggio Emilia, Italy, Pommier serves a global market through an extensive network of distributors, solidifying its position as a leading player in the French market for industrial vehicle accessories.

Financiere Groupe Pommier

Private Equity Round in 2007
Headquartered in Saint-Ouen-l’Aumône (Val d’Oise department), the Pommier group designs, manufactures and distributes equipment and accessories for industrial vehicle bodywork. It is the leading player in the French market and has production and distribution facilities in France and Europe.

Augure

Series C in 2006
Augure is a software company founded in 2002 in Paris, specializing in influencer marketing and public relations solutions. The company offers a platform that assists brands and agencies in managing their communication strategies by bridging the gap between traditional PR and influencer marketing. With over 1,000 clients utilizing the platform daily, Augure enables communication, PR, and public affairs teams to engage with relevant influencers, streamline campaign management, and enhance their media presence on social networks. In addition to its software, Augure provides consulting services through its data services team, helping clients interpret and leverage data to optimize their influencer marketing strategies. The company operates primarily in Europe and Latin America, serving a diverse range of clients, including prominent organizations in the corporate sector.

Aerowatt SA

Acquisition in 2006
Aérowatt is an independent player in the wind energy market in France and French overseas departments and territories.

SuperSonic Imagine

Series A in 2006
SuperSonic Imagine SA is a medical technology company based in Aix-en-Provence, France, specializing in the development and manufacture of ultrasound imaging systems. Founded in 2005, the company is recognized for its Aixplorer system, which delivers high-definition, high-contrast imaging crucial for diagnosing and monitoring various conditions, including breast, prostate, and thyroid cancers, as well as liver diseases. SuperSonic Imagine also offers the ShearWave technology platform, which focuses on quantitative elastography for assessing tissue elasticity. The company operates primarily in France, the United States, and China, and distributes its products through a network of offices and partners across various countries, including Belgium, Germany, and the United Kingdom. As a subsidiary of Hologic Hub Ltd, SuperSonic Imagine continues to innovate in the field of medical imaging technology, enhancing the capabilities of healthcare practitioners.

Groupe Frères Blanc

Acquisition in 2006
Groupe Frères Blanc is a prominent player in the French gastronomy sector, operating a network of 15 esteemed restaurants and brasseries in Paris, Provence, and internationally. Established in the 1950s by brothers Pierre and Jacques Blanc, the group has built a reputation for exceptional dining experiences, showcasing quality cuisine and the French art de vivre. In addition to its restaurant operations, the company also offers online reservation services for both individual and group bookings, enhancing customer convenience. Based in Paris, Groupe Frères Blanc continues to be a significant influence in the culinary landscape of France.

DxO

Series A in 2006
DxO, established in 2002 and headquartered in Boulogne, France, specializes in the development and sale of digital image processing products and solutions. Its primary offerings include DxO Optics Pro, a software application for image correction and enhancement, and DxO FilmPack, which gives digital images the style of conventional films. Additionally, DxO licenses its intellectual property of optics and silicon architectures for embedded still and video image processing in camera phones and digital cameras. The company also provides DxO Analyzer, an image quality evaluation solution. DxO serves a diverse range of customers, from consumer electronics manufacturers to photographers and imaging experts, distributing its products through resellers and distributors.

Micromania

Private Equity Round in 2006
Micromania, founded in 1983, is the premier video game retailer in France, operating 332 stores nationwide. Since Pierre Cuilleret took the helm in 2005, the company has expanded significantly, adding over 130 locations within three years. Micromania specializes in a wide array of video games, including genres such as football, board, survival, cooking, racing, and narrative-driven titles. In addition to game sales, the retailer offers rental options for gaming consoles, headphones, and remotes, enhancing the gaming experience for its customers. With a strong focus on personalized customer service and a dedicated team passionate about video games, Micromania has established a robust brand reputation, generating annual revenues exceeding €500 million.

Leyton

Private Equity Round in 2006
Leyton is a consulting firm headquartered in Paris, France, founded in 1997. Specializing in cost optimization, Leyton provides a range of services including tax credit research, start-up consulting, purchase optimization, insurance audits, and management of receipts. The firm has developed significant expertise in optimizing Federal and State Research and Development (R&D) Tax Credits in the United States. With over 20 years of global experience, Leyton boasts a team of highly qualified tax professionals and technical consultants, making it one of the largest innovation funding specialists worldwide. The firm serves a diverse array of industries, including software, engineering, manufacturing, food and beverage, and architecture, ensuring that its clients benefit from tailored insights and solutions. Leyton’s commitment to technical knowledge is exemplified by its substantial team dedicated to R&D Tax claims, allowing for maximized claims and informed guidance based on industry-specific challenges.

SOURIAU SAS

Acquisition in 2006
Founded in 1917, and headquartered in Versailles, France, the Souriau Group designs, manufactures and markets high performance - high reliability interconnect solutions for severe environments dedicated to the Aerospace, Defense / Space, Heavy Industry (Railway & Mass Transit, Nuclear, Oil & Gas) and Industrial Equipment markets. Souriau has a worldwide presence with R & D centers and production sites in Europe, the United States, Japan, India, Morocco and Dominican Republic.

Eptica

Series C in 2005
Eptica S.A. is a company that specializes in designing and developing customer relationship management (CRM) software for business-to-business marketplaces. Founded in 2001 and headquartered in Boulogne-Billancourt, France, Eptica offers solutions that facilitate real-time interactions between enterprises, clients, suppliers, and partners through multiple digital channels. Its software includes features for social customer service, email management, chat, and knowledge management, enabling organizations to enhance customer engagement and drive sales through personalized communication. Additionally, Eptica provides professional services such as technical support, training, and consulting, catering to various sectors including banking, insurance, retail, tourism, and public institutions. As of October 2019, Eptica operates as a subsidiary of Enghouse Systems Limited.

OpenTrust

Series C in 2005
OpenTrust is a company that designs and develops versatile solutions aimed at addressing complex security challenges in modern enterprises. Founded in 2000 and based in Paris, France, OpenTrust provides a range of software products and cloud security services to governments, financial institutions, and enterprises, facilitating the management of digital identities and securing electronic transactions and documents. Its offerings include certificate-based strong authentication, smart card management, secure document exchange, digital signatures, and proof management. The OpenTrust platform is compatible with various technologies from leading vendors and is available both as licensed software and private cloud services. Additionally, OpenTrust provides professional services to assist in product integration and offers a comprehensive training and certification program. Its solutions are utilized by numerous multinational enterprises, with more than 2 billion users across 100 countries.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.